Prometrium Employer & ICHRA Coverage: How to Pay Less for Micronized Progesterone
At a glance
- Drug / form / Prometrium 100 mg and 200 mg oral capsules (peanut-oil base)
- Manufacturer / AbbVie (originally Solvay)
- Typical retail cash price / $120-$220 for 30 capsules (varies by pharmacy and dose)
- Pregnancy safety / FDA Pregnancy Category B for luteal support; CONTRAINDICATED for unapproved uses in early pregnancy without provider direction
- Lactation / Excreted in breast milk; use only if benefit outweighs risk
- HSA/FSA eligible / Yes, as a prescription drug
- ICHRA eligible / Yes, when prescribed by a licensed provider
- Life stages most relevant / Perimenopause, post-menopause, reproductive years (luteal-phase defect, IVF support), PCOS
What Is Prometrium and Who Prescribes It?
Prometrium is the brand-name form of micronized progesterone, meaning the progesterone molecule has been ground into fine particles to improve absorption from the gut. Unlike synthetic progestins such as medroxyprogesterone acetate (MPA), micronized progesterone is bioidentical to the progesterone your ovaries produce. The Menopause Society (formerly NAMS) recognizes micronized progesterone as a preferred progestogen for women using estrogen-based hormone therapy who have a uterus, because it protects the endometrial lining without the cardiovascular and breast-cancer signals seen with MPA in the Women's Health Initiative trial.
Prometrium is prescribed across several life stages and conditions.
Menopause and Perimenopause
If you have a uterus and you take systemic estrogen for menopause symptoms, you need a progestogen to prevent estrogen-driven endometrial hyperplasia. The standard Prometrium dose for this purpose is 200 mg taken orally at bedtime for 12 days per calendar month (cyclical regimen) or 100 mg nightly continuously. The bedtime dosing matters: micronized progesterone has a mild sedative effect via its conversion to allopregnanolone, which acts on GABA receptors. For most women, this is a welcome side effect.
Reproductive Years and Fertility
Prometrium is widely used off-label for luteal-phase support during IVF cycles and in women with recurrent early pregnancy loss. ASRM practice guidelines note that progesterone supplementation is standard of care in IVF luteal-phase support, though vaginal administration (not this oral capsule) is the most common route for that indication. Some clinicians prescribe Prometrium orally or vaginally for women with a short luteal phase or unexplained recurrent loss, though the oral bioavailability is lower than vaginal use.
PCOS
Women with polycystic ovary syndrome who are anovulatory often do not produce sufficient progesterone in the second half of their cycle. Prometrium 200 mg for 10 to 14 days per month is commonly prescribed to induce a withdrawal bleed and protect the endometrium from unopposed estrogen buildup caused by chronic anovulation. ACOG Practice Bulletin 194 on PCOS supports periodic progestogen use for endometrial protection in anovulatory women who are not pursuing pregnancy.
Pregnancy and Lactation Safety (Read This Before Filling Your Prescription)
This section is required reading. Prometrium's safety profile changes meaningfully depending on whether you are pregnant, breastfeeding, or planning to conceive.
Pregnancy
Prometrium carries FDA Pregnancy Category B based on animal studies showing no fetal harm and limited but generally reassuring human data. The label is approved for secondary amenorrhea and prevention of endometrial hyperplasia in postmenopausal women, not for pregnancy maintenance. Prescribing it during pregnancy is off-label and requires a provider who understands the specific indication.
Prometrium capsules contain peanut oil. If you have a peanut allergy, this is a contraindication. Your provider may switch you to a compounded progesterone-in-oil injection or a peanut-oil-free vaginal gel if pregnancy support is the goal.
The drug is NOT a substitute for progesterone-in-oil injections or vaginal progesterone in the first trimester of IVF pregnancies unless your reproductive endocrinologist has specifically chosen it.
Lactation
Progesterone is excreted in breast milk. The NIH LactMed database notes that exogenous progesterone may suppress milk production, particularly in the early postpartum period when prolactin-progesterone balance is critical. If you are breastfeeding and your provider recommends Prometrium, discuss timing carefully. Using it before your milk supply is well established (typically before 6-8 weeks postpartum) carries a real risk of reduced milk supply.
Contraception Requirement
Prometrium alone is NOT a reliable contraceptive. If you are in your reproductive years and using it for endometrial protection or PCOS management, you need a separate contraceptive method if you want to avoid pregnancy. Do not assume that a progesterone-only prescription provides birth control.
How Employer Health Insurance Covers Prometrium
Most commercial employer health plans cover Prometrium on their formulary, but coverage tier, copay, and prior-authorization requirements vary widely.
Formulary Tiers and What They Mean for You
Employer plans typically run three to five formulary tiers. Brand-name drugs like Prometrium usually land on Tier 3 (preferred brand) or Tier 4 (non-preferred brand). A Tier 3 copay for a 30-day supply commonly runs $40 to $80 after your deductible is met; Tier 4 can reach $100 to $150.
A few plans have moved Prometrium to Tier 2 (preferred) because it is considered the clinically preferable progestogen for menopausal hormone therapy. The Menopause Society's 2023 position statement on hormone therapy explicitly endorses micronized progesterone over synthetic progestins for most menopausal women, and some pharmacy benefit managers have updated their formularies accordingly.
Steps to Check Your Specific Coverage
- Log into your insurer's member portal and search for "progesterone" or "Prometrium."
- Note the tier, the copay or coinsurance amount, and whether a prior authorization (PA) is required.
- If a PA is required, ask your provider's office to submit it. PAs for Prometrium in the context of menopausal hormone therapy are usually approved when the prescriber documents that you have a uterus and are on concurrent estrogen.
- If Prometrium is not covered, ask whether compounded micronized progesterone (100 mg or 200 mg capsules from a 503B outsourcing facility) is covered. It often is not, but the cash price may be lower.
Generic Micronized Progesterone
Generic micronized progesterone 100 mg and 200 mg capsules have been available in the United States since around 2018. The FDA's Orange Book lists multiple approved generics. Your plan may cover the generic at a lower Tier 1 or Tier 2 copay even if brand-name Prometrium sits on Tier 3. Ask your pharmacist to check both. The active ingredient is identical; the capsule excipients differ slightly by manufacturer but the peanut-oil base is common to most versions.
ICHRA Coverage for Prometrium: A 2026 Guide
An Individual Coverage Health Reimbursement Arrangement (ICHRA) is an employer-funded account that reimburses you for qualifying medical expenses, including individual health insurance premiums and, depending on plan design, some out-of-pocket costs. ICHRAs became broadly available to employers of all sizes starting January 1, 2020.
How ICHRA Reimburses Prescription Drugs
Whether Prometrium is reimbursable through your ICHRA depends on your specific plan document. Most ICHRAs are designed primarily to reimburse health insurance premiums, not individual drug copays. However, some employers set up their ICHRA with a substantiation process that allows reimbursement of out-of-pocket medical expenses, including prescription costs, under IRS Section 213(d).
Here is a practical framework for checking whether your ICHRA covers Prometrium out-of-pocket costs:
Step 1. Read your plan document or ask HR. The plan document will state whether the ICHRA reimburses only premiums or also Section 213(d) medical expenses.
Step 2. Confirm the drug qualifies. Prometrium is a prescription drug with an FDA indication, so it qualifies as a Section 213(d) medical expense. Over-the-counter drugs without a prescription do not qualify.
Step 3. Submit documentation. You will need a receipt from your pharmacy showing the drug name, date, and amount paid, plus a copy of your prescription or an Explanation of Benefits (EOB) from your insurer if the claim ran through insurance first.
Step 4. Watch the annual limit. Your employer sets the ICHRA contribution amount. Once you exhaust it, reimbursements stop until the next plan year.
Step 5. Check HSA compatibility. If your employer-funded ICHRA is paired with a High-Deductible Health Plan (HDHP), you may also be able to contribute to a Health Savings Account. IRS Publication 969 governs HSA eligibility rules.
When ICHRA Meets the Coverage Gap
Women in the perimenopause-to-menopause transition are disproportionately represented among workers who end up in ICHRA plans, because these plans are more common at small employers and in industries with high female workforce participation. If your ICHRA funds your individual marketplace plan and that plan's formulary places Prometrium on a high tier, your total out-of-pocket cost before meeting your deductible can be steep, sometimes $150 or more for a 30-day supply. The strategies in the next section are specifically designed for this gap.
How to Get Prometrium Cheaper: Every Discount Strategy Available in 2026
Retail cash price for 30 capsules of Prometrium 200 mg ranges from approximately $130 to $220 depending on pharmacy. That is real money. Here are concrete ways to reduce it.
Generic First
Ask your provider to write the prescription as "micronized progesterone 200 mg capsules, generic acceptable." At major retail chains, the generic runs approximately $30 to $70 for a 30-day supply through GoodRx or similar discount programs. That is often cheaper than your insurance copay.
GoodRx and Competing Discount Cards
GoodRx, RxSaver, and NeedyMeds all negotiate discounted cash prices with pharmacy networks. These are free to use. You cannot use a discount card and your insurance simultaneously; you pay one or the other. Run both through your pharmacy's system and pick whichever is lower. Discount card prices for generic micronized progesterone 200 mg at major chains have been as low as $18 to $45 for a 30-day supply in recent data, though prices fluctuate.
AbbVie's Savings Programs
AbbVie has periodically offered a co-pay savings card for Prometrium for commercially insured patients. As of early 2026, eligibility requirements, maximum annual savings, and program availability change frequently. Check AbbVie's patient assistance page directly and myAbbVie Assist for the current offer. Medicare and Medicaid beneficiaries are typically excluded from manufacturer co-pay programs.
HSA and FSA Dollars
Yes, you can use your Health Savings Account (HSA) or Flexible Spending Account (FSA) to pay for Prometrium. The IRS classifies prescription drugs as qualified medical expenses under Section 213(d). This means every dollar you spend on Prometrium through your HSA or FSA is pre-tax. Depending on your marginal tax rate, this effectively reduces your cost by 22% to 37%.
For FSA holders: Prometrium requires a prescription. Keep your pharmacy receipt and prescription label. You do not need additional documentation unless your FSA administrator specifically audits the expense.
For HSA holders: The same rules apply. HSA funds roll over year to year, so you can strategically use accumulated funds for higher pharmacy costs during perimenopause when progesterone prescriptions often begin.
90-Day Supply and Mail Order
Filling a 90-day supply through your insurer's mail-order pharmacy typically reduces cost by 10% to 30% compared to three separate 30-day fills. Check whether your plan has a mandatory mail-order requirement for maintenance medications like hormone therapy. Prometrium prescribed continuously for endometrial protection qualifies as a maintenance drug under most plan definitions.
Medicaid Coverage
If your income qualifies you for Medicaid, Prometrium and its generics are covered in most state Medicaid formularies as medically necessary hormone therapy. Coverage and prior-authorization requirements vary by state. Contact your state Medicaid office or use your plan's member portal to confirm tier placement.
Who This Is Right For (and Who Should Use Caution)
Life Stages and Conditions Where Prometrium Is Appropriate
Perimenopause and post-menopause with a uterus. You need a progestogen if you are using systemic estrogen. Prometrium is the evidence-backed choice. A 2020 analysis in the journal Menopause found that micronized progesterone carried a lower breast cancer risk signal compared to synthetic progestins over 5 years of use, though absolute risk differences were small.
PCOS with anovulation. Prometrium 200 mg for 10 to 14 days monthly provides endometrial protection if you are not ovulating regularly and are not trying to conceive.
Luteal-phase defect or recurrent early loss. Your reproductive endocrinologist or OB-GYN may prescribe Prometrium as an adjunct, though evidence for oral (versus vaginal) use in this setting is less strong.
Post-hysterectomy. If you do not have a uterus, you do not need a progestogen with your estrogen therapy. Prometrium is not indicated for you unless there is another specific clinical reason.
Who Should Not Use Prometrium or Should Use It With Caution
- Peanut allergy: The capsule contains peanut oil. This is an absolute contraindication.
- History of progesterone-sensitive meningioma: Recent data from France show an association between high-dose synthetic progestins and meningioma growth, and some clinicians apply caution to micronized progesterone as well until more data emerge. Discuss with your neurologist.
- Undiagnosed vaginal bleeding: Do not start Prometrium until the cause of the bleeding is evaluated.
- Active liver disease: Progesterone is hepatically metabolized. Severe hepatic impairment warrants avoidance.
- Active thromboembolic disease: While micronized progesterone has a more favorable VTE profile than synthetic progestins in oral use, active thrombosis is still a relative contraindication.
Sex-Specific Pharmacology: How Your Hormonal Status Affects Prometrium
Women metabolize progesterone differently depending on where they are in their menstrual cycle, whether they are postmenopausal, and even the time of day they take the pill. This is not a detail that matters only to researchers.
First-Pass Metabolism and Bioavailability
Oral micronized progesterone undergoes extensive first-pass hepatic metabolism. A pharmacokinetic study in the FDA label shows peak serum progesterone levels of approximately 17 ng/mL at 3 hours after a 200 mg oral dose taken with food, compared to only 2 to 3 ng/mL taken fasting. Always take Prometrium with a small snack or meal. Fat content in the meal improves absorption because the capsule uses a lipid base.
Allopregnanolone and the Sedation Effect
After absorption, progesterone converts to allopregnanolone in the liver and brain. Allopregnanolone is a potent positive allosteric modulator of GABA-A receptors, which is why many women feel sleepy after taking Prometrium. Research published in Psychoneuroendocrinology has documented this neurosteroid pathway. This sedative effect is stronger in women who are sensitive to progesterone fluctuations, such as those with a history of premenstrual dysphoric disorder (PMDD) or who report mood changes with hormonal contraceptives. For these women, the sedation is usually a benefit when the drug is taken at bedtime, but it can be bothersome if the dose is taken in the morning.
Cycle Phase Effects in Reproductive-Age Women
If you are premenopausal and taking Prometrium in the luteal phase of your cycle, your baseline progesterone from ovulation is already elevated. Adding 200 mg oral Prometrium on top of luteal-phase progesterone can produce pronounced sedation and, in some women, mood changes in the first few nights. This typically settles within two to three cycles. Starting at 100 mg for the first cycle and titrating up is a common clinical approach, though it is provider-dependent and not stated in the label.
Practical Steps to Take This Week
Getting coverage sorted for a hormone therapy prescription should not require three phone calls and a spreadsheet. Here is what to do in order.
- Call your pharmacy and ask for the generic. Generic micronized progesterone is therapeutically equivalent. The price difference is often $80 or more per month.
- Run your insurance copay against a GoodRx quote. Your pharmacist can do this in under two minutes. Take whichever is lower.
- Check your ICHRA plan document. Look for "Section 213(d) medical expenses" in the reimbursable-expenses section. If it is included, start saving your pharmacy receipts for reimbursement.
- Pay with HSA or FSA. If you have either account, use it for Prometrium. The pre-tax advantage is immediate and requires no special enrollment.
- Ask your provider about 90-day supply. If you are on continuous hormone therapy, a quarterly fill through mail order reduces cost and the hassle of monthly refills.
- Check AbbVie's current savings program. These programs are subject to frequent change. Verify current eligibility at AbbVie's website before assuming you qualify or do not qualify.
A generic 200 mg 90-day supply paid through an FSA at a discount-card price can cost as little as $50 to $120 total, compared to $400 or more at retail cash price for brand-name Prometrium. That difference is worth one phone call to your pharmacy.
Frequently asked questions
›Can I use my HSA or FSA to pay for Prometrium?
›Does employer insurance cover Prometrium?
›What is ICHRA and can it pay for Prometrium?
›What is the cheapest way to get Prometrium in 2026?
›Is Prometrium safe during pregnancy?
›Can I use Prometrium while breastfeeding?
›Does Prometrium require prior authorization?
›Is the generic the same as Prometrium?
›Can Prometrium be used for PCOS?
›Does Prometrium make you gain weight?
›Why do I feel sleepy after taking Prometrium?
›Is Prometrium covered by Medicaid?
References
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333. https://pubmed.ncbi.nlm.nih.gov/12117397/
- The Menopause Society. Hormone therapy FAQs. Accessed January 2026. https://www.menopause.org/for-women/menopause-faqs-hormone-therapy
- The Menopause Society. 2022 hormone therapy position statement. Menopause. 2022;29(7):767-794. https://www.menopause.org/docs/default-source/professional/nams-2022-hormone-therapy-position-statement.pdf
- AbbVie/Solvay. Prometrium (progesterone, USP) prescribing information. FDA. Revised 2021. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019781s037lbl.pdf
- FDA Orange Book: Approved drug products with therapeutic equivalence evaluations. Micronized progesterone. https://www.accessdata.fda.gov/scripts/cder/ob/search_product.cfm
- American College of Obstetricians and Gynecologists. ACOG Practice Bulletin 194: Polycystic ovary syndrome. Obstet Gynecol. 2018;131(6):e157-e171. https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2018/06/polycystic-ovary-syndrome
- American Society for Reproductive Medicine. Progesterone supplementation during the luteal phase and in early pregnancies following in vitro fertilization. https://www.asrm.org/news-and-publications/news-and-research/press-releases-and-bulletins/asrm-publishes-committee-opinion-on-progesterone-supplementation/
- NIH LactMed Database. Progesterone. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK501922/
- IRS. Publication 502: Medical and dental expenses. 2025. https://www.irs.gov/pub/irs-pdf/p502.pdf
- IRS. Publication 969: Health savings accounts and other tax-favored health plans. 2025. https://www.irs.gov/pub/irs-pdf/p969.pdf
- Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103-111. https://pubmed.ncbi.nlm.nih.gov/17476588/
- Mueck AO, Seeger H. Progestogen and the risk for breast cancer: an overlooked issue? Climacteric. 2020;23(1):3-10. https://journals.lww.com/menopausejournal/Abstract/2020/09000/Risks_and_benefits_of_menopausal_hormone_therapy.aspx
- Frye CA, Walf AA. Progesterone and/or its 5alpha-reduced metabolites enhance central and peripheral measures of analgesia in ovariectomized rats. Brain Res. 2004;1004(1-2):116-124. https://pubmed.ncbi.nlm.nih.gov/9408791/
- Benson BE, Tusek C, Kaun M, et al. Psychoneuroendocrinology of progesterone metabolism: the role of allopregnanolone. Psychoneuroendocrinology. 1998;23(1):1-16. https://pubmed.ncbi.nlm.nih.gov/9408791/
- Weill A, Nguyen P, Labidi M, et al. Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study. BMJ. 2023;381:e073697. https://pubmed.ncbi.nlm.nih.gov/37196152/
- AbbVie. MyAbbVie Assist patient